Global Macrolide Antibiotics Market is estimated to be US$ 118.1 Billion by 2030 with a CAGR of 11.5

Nisha Shaha22 Mar, 2022Health

The Global Macrolide Antibiotics market accounted for US$ 39.7 billion in 2020 and is estimated to be US$ 118.1 billion by 2030 and is anticipated to register a CAGR of 11.5%. Antibiotics originating from Saccharopolyspora erythraea are known as macrolide antibiotics. Macrolide antibiotics have a wide range of action against many gram-positive bacteria and are bacteriostatic in nature. Soft tissue infections, respiratory infections, sexually transmitted infections, and atypical mycobacterial infections are all treated with macrolide antibiotics. Macrolide antibiotics have anti-inflammatory and immunomodulatory properties and are used to treat a variety of ailments. Macrolide antibiotics can be used as a first- or second-line therapy, depending on the situation. Erythromycin is used as a second-line treatment for allergies and is used as a first-line treatment for pertussis and other disorders.